Gold futures rose by nearly 3% on Monday to start the new year, after putting in the best annual return in a decade, with the move for bullion to its highest finish since November coming as the dollar sank to around a 2 1/2-year nadir.
Shares of Boeing and Coca-Cola are trading lower Monday afternoon, propelling the Dow Jones Industrial Average selloff. The Dow DJIA, -1.25% was most recently trading 466 points (1.5%) lower, as shares of Boeing BA, -5.30% and Coca-Cola KO, -3.79% are contributing to the index’s intraday decline.
Majority of analysts making their first call on lodging-rental platform rate stock a ‘hold’ after biggest IPO of 2020
Shares of Tesla Inc. TSLA, +3.42% rallied 3.42% to $729.77 Monday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP, -1.47% falling 1.47% to 12,698.45 and Dow Jones Industrial Average DJIA, -1.25% falling 1.25% to 30,223.89. This was the stock’s seventh consecutive day of gains. Tesla Inc. hit a new 52-week high, surpassing its previous peak of $718.72, which the company achieved on December 31st.
A standardized “Artificial Pancreas (AP) Dashboard” should provide easy to use single-page hybrid closed-loop system (HCL) reporting for insulin-requiring patients with diabetes. The AP Dashboard will help standardize HCL reporting similar to standardized CGM reporting and an electrocardiogram (EKG) and will be likely to help improve glycemic control and reduce hypoglycemia.
Multiple drugmakers agreed to cut prices of some of their newest drugs by as much as 50% in order to receive coverage from China’s national insurance program.
Seattle-based Madrona Venture Group closed $500 million in new funds that will be used to accelerate startup tech and life science companies primarily in the Pacific Northwest.
Neurological diseases of the brain such as dementia, autism and schizophrenia are now a growing social problem. Nevertheless, studies on their definitive cause are still insufficient. Recently, a POSTECH research team has identified the mechanism in which such neurological diseases occur, thus solving the enigma to treating them.
If 2020 taught us anything, it was that unexpected things happen. That said, there are some stories we’ll be watching for. Here’s a look.
Company simultaneously effected a 1-for-4 reverse stock split
Wholesale Price Increases Accelerated in April as Inflation Remains Sticky
Biden Hikes Tariffs on Chinese EVs, Solar Cells, Steel, Aluminum — and Snipes at Trump
Alibaba’s stock slumps after another profit miss
Wall Street Ends Higher, Sending Nasdaq to a Record High
‘The Top Line’: Navigating the future of medical AI
AstraZeneca’s phase 3 heart disease trial hits, teeing up Pfizer showdown in Japan
Synchron takes stake in miniaturized implant tech maker Acquandas
Takeda drops cancer candidates, axing immunocytokine and CAR-Ts amid shifting treatment landscape
Edwards excites with Evoque FDA approval in transcatheter tricuspid valve replacement
Deal-hungry Merck plans more phase 3 launches than in 2023
